PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2516

  1. 357 Posts.
    lightbulb Created with Sketch. 46
    Hello Ceviche, Very good point you made.
    I was against US listing before, but I like your suggestion for Depository Receipts now, as I think the time is right.
    It will cost a bit, but the return will be very quick as the action is going to be in the northern hemisphere's huge OA market.
    We've recommenced the suspended 008 trial and proceeding with the large phase 3 trial in the US. The publicity alone. associated with that will increase the PAR profile enormously.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.